API response to Pfizer Australia announcement

API response to Pfizer Australia announcement

6 December 2010
ASX Announcement

Australian Pharmaceutical Industries Limited (API) has received notification from Pfizer Australia (Pfizer) that Pfizer intends to cease distributing its prescription medicines through wholesale distributors effective 31 January 2011. API is one of three wholesalers currently distributing Pfizer prescription products. Details of the Pfizer announcement can be found at pfizer.com.au/media

API is analysing the implications of this decision and further information will be provided as soon as practicable.

API contact
Stephen Roche
MD and CEO

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.